Keeping a close watch on patients after they begin taking these drugs is a good idea--although not because these medicines are especially risky or dangerous. Patients need to be monitored to ensure they're getting the right medication in the amount that can help them feel better.

People should be closely monitored, but not because these drugs are especially risky. The real problem in the treatment of depression is that people start medicine and the medicine has side effects or the medicine doesn't work right away, and they get discouraged and they drop out.

There's a possibility that it could lead to (harder drugs) with some people.

They bring a lot more baggage in these days, ... The pressures of society are stronger -- the drinking, the drugs, the social problems. They have to grow up faster and take on more responsibilities.

Most health plans already devote significant attention and resources to formulary decisions. It is our hope that formulary committees and other decision makers focus on important questions and ask for the right kinds of evidence.

astonished that a high public official would put the federal government at the service of a massive communications company.